USD 16.13
(-2.24%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 | 65.31 Billion JPY | 2.66% |
2023 | 63.62 Billion JPY | 6.1% |
2022 | 59.96 Billion JPY | 12.35% |
2021 | 53.37 Billion JPY | -21.28% |
2020 | 67.79 Billion JPY | 6.94% |
2019 | 63.39 Billion JPY | 6.31% |
2018 | 59.63 Billion JPY | 12.4% |
2017 | 53.05 Billion JPY | -2.8% |
2016 | 54.58 Billion JPY | -4.69% |
2015 | 45.12 Billion JPY | -9.88% |
2014 | 47.81 Billion JPY | 30.47% |
2013 | 53.03 Billion JPY | 8.34% |
2012 | 39.12 Billion JPY | -43.34% |
2011 | 23.35 Billion JPY | -3.99% |
2010 | 23.86 Billion JPY | -2.56% |
2009 | 36.12 Billion JPY | -10.25% |
2008 | 55.93 Billion JPY | 1.1% |
2007 | 46.24 Billion JPY | 20.67% |
2006 | 38.97 Billion JPY | 22.53% |
2005 | 28.03 Billion JPY | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 FY | - JPY | 2.66% |
2024 Q2 | 14.59 Billion JPY | -12.96% |
2024 Q3 | 33.63 Billion JPY | 67.56% |
2024 Q1 | 16.77 Billion JPY | 10.2% |
2024 Q4 | 14.69 Billion JPY | -39.93% |
2023 Q2 | 15.68 Billion JPY | -8.03% |
2023 Q4 | 15.22 Billion JPY | -14.68% |
2023 FY | - JPY | 6.1% |
2023 Q3 | 17.83 Billion JPY | 13.74% |
2023 Q1 | 17.05 Billion JPY | 39.55% |
2022 Q3 | 16.35 Billion JPY | 12.27% |
2022 FY | - JPY | 12.35% |
2022 Q1 | 16.82 Billion JPY | 31.35% |
2022 Q2 | 14.56 Billion JPY | -13.42% |
2022 Q4 | 12.22 Billion JPY | -25.27% |
2021 Q4 | 12.8 Billion JPY | -32.32% |
2021 Q2 | 13.6 Billion JPY | -19.04% |
2021 Q1 | 16.8 Billion JPY | -2.62% |
2021 FY | - JPY | -21.28% |
2021 Q3 | 18.92 Billion JPY | 39.07% |
2020 Q2 | 22.31 Billion JPY | 19.17% |
2020 Q4 | 17.26 Billion JPY | -22.78% |
2020 FY | - JPY | 6.94% |
2020 Q1 | 18.72 Billion JPY | 14.55% |
2020 Q3 | 22.35 Billion JPY | 0.17% |
2019 FY | - JPY | 6.31% |
2019 Q4 | 16.34 Billion JPY | -34.12% |
2019 Q3 | 24.81 Billion JPY | 40.26% |
2019 Q2 | 17.68 Billion JPY | 1.17% |
2019 Q1 | 17.48 Billion JPY | 4.88% |
2018 Q3 | 23.24 Billion JPY | 34.84% |
2018 Q2 | 17.24 Billion JPY | 13.06% |
2018 Q1 | 15.24 Billion JPY | 13.12% |
2018 FY | - JPY | 12.4% |
2018 Q4 | 16.67 Billion JPY | -28.28% |
2017 Q3 | 19.38 Billion JPY | 27.69% |
2017 FY | - JPY | -2.8% |
2017 Q1 | 17.9 Billion JPY | 6.91% |
2017 Q4 | 13.48 Billion JPY | -30.47% |
2017 Q2 | 15.18 Billion JPY | -15.21% |
2016 FY | - JPY | -4.69% |
2016 Q4 | 16.74 Billion JPY | -16.31% |
2016 Q1 | 13.77 Billion JPY | -7.41% |
2016 Q2 | 15.9 Billion JPY | 15.47% |
2016 Q3 | 20.01 Billion JPY | 25.81% |
2015 Q3 | 15.46 Billion JPY | 22.68% |
2015 Q2 | 12.6 Billion JPY | -0.05% |
2015 Q4 | 14.87 Billion JPY | -3.77% |
2015 FY | - JPY | -9.88% |
2015 Q1 | 12.6 Billion JPY | -12.99% |
2014 Q1 | 16.59 Billion JPY | 67.18% |
2014 FY | - JPY | 30.47% |
2014 Q2 | 14.65 Billion JPY | -11.7% |
2014 Q4 | 14.49 Billion JPY | -10.45% |
2014 Q3 | 16.18 Billion JPY | 10.46% |
2013 Q4 | 9.92 Billion JPY | 208.94% |
2013 Q2 | 23.15 Billion JPY | 61.81% |
2013 Q1 | 14.3 Billion JPY | -38.65% |
2013 Q3 | -9.11 Billion JPY | -139.35% |
2013 FY | - JPY | 8.34% |
2012 Q1 | 18.54 Billion JPY | 21.29% |
2012 Q2 | 21.87 Billion JPY | 17.99% |
2012 FY | - JPY | -43.34% |
2012 Q4 | 23.31 Billion JPY | 5.45% |
2012 Q3 | 22.11 Billion JPY | 1.08% |
2011 Q3 | 15.34 Billion JPY | -37.35% |
2011 FY | - JPY | -3.99% |
2011 Q4 | 15.28 Billion JPY | -0.38% |
2011 Q1 | 24.21 Billion JPY | 29.99% |
2011 Q2 | 24.49 Billion JPY | 1.15% |
2010 Q1 | 18.67 Billion JPY | 15.65% |
2010 Q2 | 22.46 Billion JPY | 20.34% |
2010 Q3 | 22.84 Billion JPY | 1.65% |
2010 Q4 | 18.62 Billion JPY | -18.44% |
2010 FY | - JPY | -2.56% |
2009 FY | - JPY | -10.25% |
2009 Q4 | 16.14 Billion JPY | -25.77% |
2009 Q3 | 21.74 Billion JPY | 2.87% |
2009 Q2 | 21.14 Billion JPY | 0.0% |
2008 FY | - JPY | 1.1% |
2007 FY | - JPY | 20.67% |
2006 FY | - JPY | 22.53% |
2005 FY | - JPY | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
China Medicine Corporation | 13.27 Million USD | -491772.539% |
DH Enchantment Inc. | -145.23 Thousand USD | 44972213.2% |
Exlites Holdings International, Inc. | -90.49 Thousand USD | 72174743.343% |
Itonis, Inc. | -38.31 Thousand USD | 170485612.921% |
One Step Vending Corp. | -26.55 Thousand USD | 245981570.322% |
MediPal Holdings Corporation | 431.52 Million USD | -15035.462% |
PD-Rx Pharmaceuticals, Inc. | -51.41 Thousand USD | 127021240.046% |
Pharmagen, Inc. | -2.89 Million USD | 2257280.241% |
Suzuken Co., Ltd. | 340.78 Million USD | -19065.599% |